Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Gynecologic 1

Conditions

Ovarian Neoplasms 57 Carcinoma, Ovarian Epithelial 28 Fallopian Tube Neoplasms 20 Uterine Cervical Neoplasms 17 Endometrial Neoplasms 17 Breast Neoplasms 13 Stomach Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Lung Neoplasms 9 Prostatic Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Parkinson Disease 4, Autosomal Dominant Lewy Body 7 Esophageal Neoplasms 7 Carcinoma, Renal Cell 7 Peritoneal Neoplasms 6 Melanoma 6 Uterine Neoplasms 4 Urinary Bladder Neoplasms 4 Small Cell Lung Carcinoma 4 Sarcoma 4 Pancreatic Neoplasms 4 Neoplasms 4 Head and Neck Neoplasms 4 Esthesioneuroblastoma, Olfactory 4 Colorectal Neoplasms 4 Carcinoma, Transitional Cell 4 Triple Negative Breast Neoplasms 3 Salivary Gland Neoplasms 3 Kidney Neoplasms 3 Brenner Tumor 3

Interventions

Neoadjuvant Therapy 2 Docetaxel 1 Cytoreduction Surgical Procedures 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm, Residual × Docetaxel × Gynecologic × Clear all

NCT00551577 2007-10-31

PRIMOVAR-1

University Hospital, Bonn

Phase 2 Unknown

Ovarian Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon ⚡